ThePeptide.expert
Database

Peptide profiles.

Filter by category, search by name. Each profile is graded on a five-tier evidence scale.

10 profiles

GHK-Cu

Copper peptide / Glycyl-L-histidyl-L-lysine-Cu²⁺

Cat 1 — 2026
injectabletopical
Evidence

Naturally occurring copper-binding peptide found in human plasma. Declines significantly with age. Influences over 4,000 genes. Strongest evidence base for topical skin applications.

Thymosin Alpha-1

Tα1 / Thymalfasin / Zadaxin

Cat 1 — 2026
injectable
Evidence

28-amino acid immune-modulating peptide derived from the thymus gland. Approved in 70+ countries as Zadaxin. Among the most clinically validated peptides globally.

Epitalon

Epithalamin / Tetrapeptide AEDG

Cat 2 — review
injectablenasal
Evidence

Pineal gland-derived tetrapeptide studied for telomere lengthening via telomerase activation. 40+ years of Russian research by Dr. Vladimir Khavinson. Under FDA review for Category 1 status.

MOTS-c

Mitochondrial ORF of 12S rRNA type-c

Cat 1 — 2026
injectable
Evidence

Mitochondria-derived peptide discovered in 2015. Acts as an exercise mimetic by activating the same metabolic pathways triggered by physical activity. Levels naturally decline with age.

GLOW Blend

AminoClub GLOW / Cellular Peptide Blend

Cat 1 — 2026
injectable
Evidence

A proprietary AminoClub peptide blend formulated for skin rejuvenation, cellular repair, and anti-aging. Combines synergistic peptides targeting collagen synthesis, skin barrier function, and cellular regeneration.

KLOW Blend

AminoClub KLOW / Cellular Peptide Blend

Cat 1 — 2026
injectable
Evidence

A proprietary AminoClub peptide blend formulated for metabolic optimization, body composition, and longevity. Targets the GH axis, metabolic pathways, and cellular health simultaneously.

SS-31

Elamipretide / MTP-131 / Bendavia

RUO only
injectable
Evidence

Mitochondria-targeted tetrapeptide that protects the inner mitochondrial membrane. Reduces oxidative stress and restores ATP production. In Phase II and III clinical trials for heart failure and Barth syndrome.

Argireline

Acetyl Hexapeptide-3 / Acetyl Hexapeptide-8

Cat 1 — 2026
topical
Evidence

Topical SNARE-inhibiting peptide that reduces facial expression lines by decreasing muscle contraction intensity. Often called a Botox alternative. Multiple human RCTs with wrinkle reduction data.

Matrixyl

Palmitoyl Pentapeptide-4 / Pal-KTTKS / Matrixyl 3000

Cat 1 — 2026
topical
Evidence

Signal peptide that mimics collagen breakdown fragments to stimulate fibroblasts to produce collagen elastin and fibronectin. One of the most evidence-backed topical cosmetic peptides with replicated human RCT data.

SNAP-8

Acetyl Octapeptide-3 / Extended Argireline

Cat 1 — 2026
topical
Evidence

Extended Argireline analogue with two additional amino acids for potentially greater SNARE inhibition at lower concentration. Often combined with Argireline for additive expression line reduction.